Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Spirito

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
JAMA|July 27, 2007
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Win-Kuang Shen, et al.
The American Journal of Cardiology|June 1, 2015
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic CardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
The American Journal of Cardiology|August 14, 2022
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert PanelBarry J Maron, Joseph A Dearani, Nicholas G Smedira, et al.
Journal of the American College of Cardiology|March 19, 2013
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Michael J Ackerman, et al.
Circulation|August 6, 2014
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
JAMA|July 27, 2007
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Win-Kuang Shen, et al.
The American Journal of Cardiology|June 1, 2015
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic CardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
The American Journal of Cardiology|August 14, 2022
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert PanelBarry J Maron, Joseph A Dearani, Nicholas G Smedira, et al.
Journal of the American College of Cardiology|March 19, 2013
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathyBarry J Maron, Paolo Spirito, Michael J Ackerman, et al.
Circulation|August 6, 2014
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
Pageof 5